CONNECT WITH US
AI & Deeptech

AI & Deeptech

Making ChatGPT better for clinicians

OpenAI News logo

Published on

Add as a preferred source on Google
Making ChatGPT better for clinicians

Built for clinical work, ChatGPT for Clinicians is now available for free to verified individual clinicians in the U.S.

We’re introducing ChatGPT for Clinicians, a version of ChatGPT designed to support clinical tasks like documentation and medical research so clinicians can focus on delivering high-quality patient care. We’re making it free for any verified physician, NP, PA, or pharmacist, starting in the U.S.

The U.S. healthcare system today is under extraordinary strain. Clinicians are being asked to care for more patients while managing growing administrative demands and a rapidly expanding body of medical research. Many are already turning to AI tools like ChatGPT for support. According to a 2026 survey by the American Medical Association⁠(opens in a new window), physician use of AI is now at an all-time high, with 72% of physicians reporting they now use AI in clinical practice, up from 48% last year. Today, millions of clinicians worldwide use ChatGPT to support their clinical care every week, for applications like care consult, writing and documentation, and medical research. Clinician usage of ChatGPT has more than doubled over the past year.

As demand for AI in clinical settings grows, so does the responsibility to continuously improve our model’s performance and safety on clinical use cases and offer solutions that can safely and effectively support healthcare workflows. Earlier this year, we introduced ChatGPT for Healthcare, ⁠ which allows organizations to deploy ChatGPT to clinicians, administrators, and researchers with the compliance and controls they need at scale.



Source link
Related Topics:AI & Deeptech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.